Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo, Omicsoft Combine MetaCore and Array Studio for Deeper NGS Data Analysis


GeneGo and Omicsoft said this week that they have integrated MetaCore, GeneGo's suite of data-mining tools, with Array Studio, Omicsoft's data analysis and visualization software package, to promote in-depth analysis of next-generation sequence data.

In addition, the partners also integrated Array Studio with MetaDrug, GeneGo's pharmacology platform that is used to predict the effects of small-molecule compounds on the human body.

In January, GeneGo announced that it would distribute Omicsoft's Array Studio and Array Server software, a decision the GeneGo said grew out of discussions for an integration agreement with the firm (BI 01/08/2010).

"Omicsoft is delighted to continue its partnership with GeneGo, as the -omics field enters a new era with next-generation sequencing technology" Jack Liu, Omicsoft's president, said in a statement. He also said that the partnership is "key" to successfully tapping into the "extra benefits" provided by NGS platforms for applications such as discovering biomarkers for cancer.

Designed to analyze NGS, microarray, SNP, and copy number variation data, Array Studio lets users detect exon junctions during sequence alignment, detect fusion genes, calculate expression values, and detect and annotate mutations for DNA-seq and RNA-seq data, among other features.

The software supports microarray, SNP/genotype, and copy number platforms from Affymetrix, Illumina, and Agilent, and includes proprietary sequence-alignment algorithms for Illumina's Genome Analyzer, Roche's 454 platform, and Life Technologies' SOLiD.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.